NYSE:MRK   Merck & Company, Inc.
Still trying to figure out this stock after it FOMO'd us into some $100 calls on the COVID pill. Alot of other good pipeline drugs and news, with COVID news out there and this consolidating, could take one more try at this. Looking at 12/31 calls, any of them between $75 and $80 seem reasonable.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.